Ned Braunstein

Executive Vice President, Regulatory Affairs, Global Patient Safety and Development Quality · Regeneron Pharmaceuticals

Biopharmaceuticals

Ned Braunstein is executive vice president of regulatory affairs, global patient safety and development quality at Regeneron Pharmaceuticals. He joined in 2009 after academic medicine at Columbia University and clinical and regulatory responsibilities at Merck.

Last reviewed: Oct 21, 2026

Ned Braunstein

Executive Vice President, Regulatory Affairs, Global Patient Safety and Development Quality Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Ned Braunstein is executive vice president of regulatory affairs, global patient safety and development quality at Regeneron Pharmaceuticals. He joined in 2009 after academic medicine at Columbia University and clinical and regulatory responsibilities at Merck.

Career Highlights

  • Joined Regeneron in 2009.
  • Spent thirteen years in academic medicine at Columbia University.
  • Worked for nine years at Merck in clinical research, regulatory affairs and global human health.

Professional Journey

Braunstein worked at Columbia University College of Physicians and Surgeons for thirteen years, first as an assistant professor and later as an associate professor of Medicine.

He subsequently spent nine years at Merck in positions of increasing responsibility across clinical research, regulatory affairs and global human health. This experience brought academic medicine together with pharmaceutical development and regulation.

He joined Regeneron in 2009 and now serves as executive vice president of Regulatory Affairs, Global Patient Safety and Development Quality. His portfolio combines the regulatory and safety functions associated with medicine development with oversight of development quality.

Education

Braunstein earned a BS in medicine and an MD from Northwestern University.